key: cord-0962041-007dtmy2
authors: Youn, So-Youn; Lee, Ji-Youn; Bae, You-Chan; Kwon, Yong-Kuk; Kim, Hye-Ryoung
title: Genetic and Pathogenic Characterization of QX(GI-19)-Recombinant Infectious Bronchitis Viruses in South Korea
date: 2021-06-17
journal: Viruses
DOI: 10.3390/v13061163
sha: 6bba510e735e03b601d211352d1650134940844d
doc_id: 962041
cord_uid: 007dtmy2

Infectious bronchitis viruses (IBVs) are evolving continuously via genetic drift and genetic recombination, making disease prevention and control difficult. In this study, we undertook genetic and pathogenic characterization of recombinant IBVs isolated from chickens in South Korea between 2003 and 2019. Phylogenetic analysis showed that 46 IBV isolates belonged to GI-19, which includes nephropathogenic IBVs. Ten isolates formed a new cluster, the genomic sequences of which were different from those of reference sequences. Recombination events in the S1 gene were identified, with putative parental strains identified as QX-like, KM91-like, and GI-15. Recombination detection methods identified three patterns (rGI-19-I, rGI-19-II, and rGI-19-III). To better understand the pathogenicity of recombinant IBVs, we compared the pathogenicity of GI-19 with that of the rGI-19s. The results suggest that rGI-19s may be more likely to cause trachea infections than GI-19, whereas rGI-19s were less pathogenic in the kidney. Additionally, the pathogenicity of rGI-19s varied according to the genotype of the major parent. These results indicate that genetic recombination between heterologous strains belonging to different genotypes has occurred, resulting in the emergence of new recombinant IBVs in South Korea.

Infectious bronchitis (IB) is a highly contagious disease of poultry caused by the infectious bronchitis virus (IBV); the disease can lead to significant economic damage to the poultry industry [1, 2] . IBV, which affects chickens of all ages and species, causes respiratory, urinary, and reproductive infections [3] . Furthermore, damage to the tracheal cilia means that chickens infected with IBV commonly develop secondary infections caused by bacteria or other pathogens; these secondary infections have a higher mortality rate [4] .

The IBV (family Coronaviridae) genome encodes spike (S), envelope (E), membrane (M), and nucleocapsid (N) structural proteins. The S gene is used for the molecular characterization of IBV isolates. The S protein, especially the S1 subunit (which is highly variable among IBVs and harbors antigenic epitopes), is associated with antigenic neutralization, hemagglutination, immune protection, and cell tropism [5] [6] [7] . Therefore, variations in the S1 subunit of the S protein mainly determine the genotype, antigenicity, and pathogenicity among IBVs [8] [9] [10] .

Many antigenic variants, serotypes, and field strains of IBV have been isolated [11] . At least 30 different IBV serotypes have been identified worldwide, and most available IBV vaccines do not provide complete cross-protection against viruses with different serotypes [12] . IBV variants are a major problem for the poultry industry. Outbreaks caused by recombinants between GI-19 and GI-13 genotypes, which emerged in China in 2016, have become common in recent years [13] . Additionally, recombinant TW IBVs between GI-19 and GI-7 have begun to spread [11] . Recombinants arise due to the high error Viruses 2021, 13, 1163 2 of 13 rate of the viral RNA-dependent RNA polymerase, which results in a high frequency of genetic mutations (e.g., gene insertions, mutations, deletions, and reconstructions) during RNA replication [6] . Owing to the continuous appearance of IBV variants showing a possible shift in serotype or pathogenicity, outbreaks of IB occur frequently, even among vaccinated flocks [14] .

Several indigenous and common IBV genotypes, such as the GI-15, GI-19 subgroups (KM91-like), and the GI-19 subgroup (GI-19-like), co-circulate in South Korea, and recombination events are thought to have occurred. The GI-15 and KM91-like IBVs, which are native viruses associated with localized outbreaks, have been co-circulating since the 1990s [15] . In particular, the KM91-like IBV (which is nephropathogenic) is associated with a high mortality rate and has caused great economic losses to the poultry industry, despite the availability of a vaccine. QX-like IBVs were introduced into South Korea between 2002 and 2003 [15] [16] [17] . Moreover, variant IBVs (recombinants between KM91-like and QX-like viruses) emerged in South Korea in 2005 and have been isolated continuously since then [18] . IB outbreaks are common, and are associated with high mortality due to nephritis and respiratory disease, despite repeated vaccinations. Therefore, we conducted genetic and pathogenic analyses of Korean IBVs isolated from 2003 to 2019 to find out whether another IBV recombination event has occurred, and whether recombinant IBVs show altered pathogenicity.

Fifty-six IBV isolates were collected from infected chickens in South Korea between 2003 and 2019 ( Table 1 ). The IBV isolates (40 from broiler, five from layer, one from breeding, and ten from native chickens) were obtained from five provinces (ten from Gyeongsang, 15 from Jeolla, 17 from Chungcheong, two from Gangwon, and 12 from Geyonggi). As Gangwon has fewer chickens than the other provinces, the number of isolates obtained from that province was less than that from other provinces.

Ten-day-old specific-pathogen free (SPF) embryonated chicken eggs were used for isolation and propagation of IBVs. Allantoic fluid from eggs infected with each isolate was harvested after incubation at 37 • C for 72 h, and then frozen at −70 • C until use. Viral RNA was extracted from virus-infected allantoic fluid using a QIAamp viral RNA mini-kit (Qiagen, Hilden, Germany). The complete S gene sequence was reverse transcribed using a Super-Script III reverse transcriptase kit (Invitrogen, Carlsbad, CA, USA) and AccuPrime Taq DNA Polymerase High Fidelity (Invitrogen). Amplification of the S gene was performed using specific primers, as described previously [19] . Gene sequencing was carried out using the custom sequencing service provided by Bionics Co., Ltd. (Daejeon, Korea). The nucleotide sequences for the S genes have been submitted to GenBank under accession numbers MW984619-MW984674.

BioEdit software version 7.0.9.0 was used to analyze and edit the generated nucleotide sequences of the S1 gene from IBV isolates [20] . The IBV reference strains (four genotypes: G1-15, KM91-like, QX-like, and GI-1) were imported from the GenBank database. Sequence analyses and alignment of the S1 gene were performed using Clustal W. The phylogenetic tree was constricted in MEGA, version 6, using the neighbor joining method, with 1000 bootstrap replicates [21] .

To identify recombination events, the S1 genomic sequence was compared with those of QX-like, GI-15, and KM91-like genotype strains (QXIBV, LX4, K210-01, and KM91). Consecutive IBV nucleotide sequences from the S1 gene, based on the multiple alignment results, were used for similarity plotting analysis using the Simplot program (v 3.5.1), with a window size of 200 bp and a step size of 20 bp [22] . 

All animal experiments were approved and supervised by the Institutional Animal Care and Use Committee (IACUC) of the Animal and Plant Quarantine Agency (APQA) of South Korea (permission number 2019-197). One-week-old white leghorn SPF chickens were purchased from a local company (Namduk SPF, Gyeonggi, the South Korea) and divided randomly into four groups (n = 20/group). The birds were housed in separate isolation units (Three-Shine INC., Daejeon, the South Korea). Three groups were infected with 100 µL of IBV (10 6.5 EID 50 per 0.1-mL dose) via the oculonasal route, and one group was infected with a phosphate-buffered saline solution. Clinical signs (sneezing, tracheal rales, and chills) were monitored daily and recorded for 21 days post-infection (dpi). Oropharyngeal (OP) and cloacal (CL) swabs were collected at 3, 5, 7, 10, 14, and 21 dpi. Three (at 3 and 7 dpi) and four (at 14 dpi) birds per group were selected randomly and sacrificed humanely. The remaining ten birds in each group were euthanatized at 21 dpi. Trachea, kidney, and cecal tonsil (CT) samples were collected carefully. To measure tracheal ciliostasis, tracheal rings were cut from the dissected trachea and examined under an inverted microscope (Eclipse Ts2, Nikon, Tokyo, Japan). The degree of ciliostasis was scored as follows: 0, 100% of cilia beating; 1, 75% of cilia beating; 2, 50% of cilia beating; 3, 25% of cilia beating; and 4, no cilia beating [23] .

IBV replication in the trachea, kidney, and CT, as well as shedding in OP and CL swabs, were examined using IBV-specific primers (IBV5 GU391 and IBV5 GL533) and a probe (IBV5 G) [24] . Viral RNA was extracted from samples and swabs using a QIAamp viral RNA mini-kit (Qiagen, Hilden, Germany). Quantitative RT-PCR was performed using a Multiplex RNA Virus Master mix (Roche Diagnostics, France). The same titrated stock of virus was used to extract and dilute each viral RNA, which was used to establish the standard curve for each viral RNA to challenge the chickens. The results indicate EID50/mL. The assay for the detection was limited to 10 1.6 -10 1.9 EID 50 /mL.

The statistical analysis of virus replication from the animal trials was performed by means of ANOVA with Bonferroni's multiple comparison test. The following notations are used to indicate significant differences between groups: * p < 0.05; ** p < 0.01; *** p < 0.001.

The IBV isolates clustered into two different genetic groups (GI-15 and GI-19). We divided GI-19 into two subgroups (KM91-like and QX-like). The S1 gene showed that the 46 isolates were classified as QX-like (40 isolates) or KM91-like (six isolates), whereas ten were classified as a new cluster, distinct from GI-19, GI-15, and GI-1 (Figure 1 ).

The sequencing results showed that the S1 genes of the IBV isolates contained insertions or deletions, resulting in a different number of nucleotides (1584-1596); hence, the S1 gene of the 56 IBV isolates encoded between 528 and 532 amino acids (data not shown).

Most IBVs circulating in China belong to the QX-like genotype and can be classified into two clusters [25] . Therefore, two strains, QXIBV and LX4, were used as parental strains to compare IBV sequences. The nucleotide and amino acid sequences of each virus were compared with those of the QXIBV (QX-like cluster I), LX4 (QX-like cluster II), KM91 (KM91-like), and K210-01 (G1-15) strains. The S1 genes of 40 QX-like IBV isolates showed high nucleotide identity with QXIBV (94.8-97.5%) and LX4 (94.4-96.3%). However, rGI-19-I (92% and 90%) rGI-19-II (89-90% and 88%), and rGI-19-III (79% and 79%) showed relatively low identity with the 40 QX-like IBV isolates. Additionally, the identity between KM91 and K281-01 with rGI-19-I (91% and 79%), rGI-19-II (93% and 79%), and rGI-19-III (80% and 89%) was variable (Figure 2 ). were compared with those of the QXIBV (QX-like cluster I), LX4 (QX-like cluster II), KM91 (KM91-like), and K210-01 (G1-15) strains. The S1 genes of 40 QX-like IBV isolates showed high nucleotide identity with QXIBV (94.8-97.5%) and LX4 (94.4-96.3%). However, rGI-19-I (92% and 90%) rGI-19-II (89-90% and 88%), and rGI-19-III (79% and 79%) showed relatively low identity with the 40 QX-like IBV isolates. Additionally, the identity between KM91 and K281-01 with rGI-19-I (91% and 79%), rGI-19-II (93% and 79%), and rGI-19-III (80% and 89%) was variable (Figure 2 ).

Percentage identity matrix of the nucleotide sequences of 56 isolates and 4 reference strains of IBV. The colorcoded pairwise identity matrix was generated from the S1 genes of 60 IBVs. Each colored cell represents the percentage identity score between two sequences (indicated horizontally to the right). The color key indicates the degree of correspondence between pairwise identities and the colors displayed in the matrix.

The Simplot program (version 3.5.1) is able to prove the presence of potential recombination regions based on the S1 genes. The QXIBV, LX4, KM91, and K281/01 strains were employed as putative parental strains, and the 56 IBV isolates were taken as queries in the Simplot analysis. Strains were fixed as recombinants if there is occurrence of any crossover between the putative parental strains. The analysis revealed three patterns based on the crossover regions ( Figure 3 ). Nine IBV recombinants (rGI-19-I and rGI-19-II) between QXIBV and KM91, and one IBV recombinant (rGI-19-III) between QXIBV and K281/01 were analyzed. The major parental strain of rGI-19-I was QXIBV, and the partial S gene might have been acquired from KM91. In addition, rGI-19-II was a recombinant of QXIBV and KM91. However, the insert position and the length of the partial S gene differed from those in rGI-19-I. The length of QXIBV (a parent strain of rGI-19-II) was longer than that of rGI-19-I. The major parent strain of rGI-19-III was K281/01, and the partial S gene might have been acquired from QXIBV; the S1 gene contained two potential crossover sites (724 and 1102 bp), and three different characteristic nucleotide regions, similar to those in K281/01 and QXIBV. Two regions of the S1 gene sequence showed high similarity with K281/01 (90% and 94% at the nucleotide (nt) level and 85% and 95% at the amino acid The color-coded pairwise identity matrix was generated from the S1 genes of 60 IBVs. Each colored cell represents the percentage identity score between two sequences (indicated horizontally to the right). The color key indicates the degree of correspondence between pairwise identities and the colors displayed in the matrix.

The Simplot program (version 3.5.1) is able to prove the presence of potential recombination regions based on the S1 genes. The QXIBV, LX4, KM91, and K281/01 strains were employed as putative parental strains, and the 56 IBV isolates were taken as queries in the Simplot analysis. Strains were fixed as recombinants if there is occurrence of any crossover between the putative parental strains. The analysis revealed three patterns based on the crossover regions (Figure 3 ). Nine IBV recombinants (rGI-19-I and rGI-19-II) between QXIBV and KM91, and one IBV recombinant (rGI-19-III) between QXIBV and K281/01 were analyzed. The major parental strain of rGI-19-I was QXIBV, and the partial S gene might have been acquired from KM91. In addition, rGI-19-II was a recombinant of QXIBV and KM91. However, the insert position and the length of the partial S gene differed from those in rGI-19-I. The length of QXIBV (a parent strain of rGI-19-II) was longer than that of rGI-19-I. The major parent strain of rGI-19-III was K281/01, and the partial S gene might have been acquired from QXIBV; the S1 gene contained two potential crossover sites (724 and 1102 bp), and three different characteristic nucleotide regions, similar to those in K281/01 and QXIBV. Two regions of the S1 gene sequence showed high similarity with K281/01 (90% and 94% at the nucleotide (nt) level and 85% and 95% at the amino acid level) and the other part of that with QXIBV (nt 96% and aa 92%). These analyses provide important evidence that recombinant IBV isolates (rGI-19-I, rGI-19-II, and rGI-19-III) descended from three putative parents: KM91-like, QX-like, and GI-15. The results of recombination analysis demonstrate that heterologous recombination occurred between IBV isolates.

In recent years, two kinds of recombinant (rGI-19-II and rGI-19-III) have emerged in South Korea. Therefore, to compare the pathogenicity of recombinants rGI-19-II and rGI-19-III with that of a non-recombinant (GI-19), we inoculated them into 1-week-old SPF chickens via the oculonasal route. A 7 or 14 dpi, we found that the tracheal ciliostasis of the three infected groups was almost completely inhibited compared with that in the mock-infected group. Of note, tracheal ciliostasis in chickens treated with rGI-19-II and GI-19 recovered almost completely by 21 dpi, whereas this was not the case for chickens receiving rGI-19-III (Table 2 ). Histopathology revealed that rGI-19-III had caused tracheal lesions until 21 dpi. The tracheal lesions involved the loss of both cilia and epithelial cells, epithelial cell degeneration, epithelial cell hyperplasia, and infiltration of the surface and lamina propria layers by inflammatory cells (Figure 4) . None of the challenge or mock-infected groups exhibited lesions in the other tissues. The tracheas of chickens infected with GI-19 displayed no evidence of infection at 3 dpi; however, infection by rGI-19s was detected. At the same point, the titers of rGI-19-III were not the highest among other infected groups in the tracheas by 14 dpi, but the titer of rGI-19-III was higher than those of G1-19 at 21 dpi (p < 0.05). Overall, tracheal infection by rGI-19s was detected earlier, and with higher titers, than infections by GI-19 ( Figure 5A) . The viral load in kidney samples from chickens infected with rGI-19-III was considerably lower than that in the other groups at 7 and 14 dpi (p < 0.01). Although the titers of GI-19 increased gradually after infection, peaking at 7 dpi before falling slightly, those of rGI-19-II remained constant up to 14 dpi, and those of rGI-19-III increased markedly in 21 dpi (p < 0.05). rGI-19 titers tended to increase at a slower rate than those of GI-19 ( Figure 5B ). In CT, the titer of viruses increased after infection. However, the titers of rGI-19 were higher than those of GI-19 at 3, 7, and 14 dpi (p < 0.05, p < 0.01, and p < 0.001) ( Figure 5C ). Thus, we speculate that rGI-19s may be better at infecting the trachea than GI-19, but less able to infect the kidney ( Figure 5 ). 

A Data are expressed as the mean score ± SD. B A ciliostasis score of 0, 1, 2, 4, and 4 corresponds to 100%, 75%, 50%, and 0% activity, respectively.

Viruses 2021, 13, x FOR PEER REVIEW 9 of 13 At 3, 5, 7, 10, 14, and 21 dpi, infected and mock-infected groups shed virus through the OP and CL routes. Viral shedding by all infected groups was detected up to 21 dpi. The titers of rGI-19s shed via the CL routes were lower than that of GI-19 at 3, 5, 7, 21 dpi (p < 0.05, p < 0.01, and p < 0.001). Additionally, the amount of virus shed via the OP route decreased from 7 dpi (GI-19 and rGI-19-II) and 5 dpi (rGI-19-III). Despite these differences in titer, all viruses were shed via the OP and CL routes by 21 dpi, with showing similar patterns ( Figure 6 ). 

Previous studies of IBV show that crossover sites occur within relatively conserved sequences close to the hypervariable region (HVR) of the S1 gene, in a conserved sequence within the HVR, and in the S2 gene [26] [27] [28] . Among the 56 Korean IBV isolates examined herein, 46 were classified as QX-like (40 isolates) or KM-91-like (six isolates); recombination events were detected in the remaining 10 isolates. All of the recombinant IBV isolates harbored crossover events in the S1 gene. We performed a detailed examination of three recombinant types: recombinants rGI-19-I and rGI-19-II (resulting from recombination between the GI-19 and KM91-like genotypes) and recombinant rGI-19-III (resulting from recombination between the GI-19 and GI-15 genotypes). From 2005 to 2019, rG1-19-II was detected consistently in different regions of South Korea. Therefore, recombinant IBVs have the potential to spread widely across poultry farms in South Korea (Table 1 and Figure 3 ). The data also indicate that this site (625 bp) may serve as a major region for template switching during viral RNA synthesis, and as a breakpoint candidate for genetic recombination within the S gene of nephropathogenic IBV isolates in South Korea. Genetic recombination can occur within multiple genes of IBVs [29] [30] [31] , which is a fact that should be considered in future research. The emergence of recombinant variants of IBV, caused by genetic mutation, has been reported in many countries. Indeed, the use of live vaccines could lead to the emergence of new variant viruses via the recombination of field strains with vaccine strains [32] . Three kinds of live vaccine have been used in South Korea (a GI-1 genotype vaccine in 1986, a KM91-like genotype vaccine in 2009, and a QX-like genotype vaccine in 2018) [17] . The IBV isolates examined in the present study were obtained both before and after the introduction of these live-attenuated IBV vaccines. Our data show evidence of recombination between IBVs isolated between 2003 and 2019 (Figures 1-3) . Therefore, it is impossible to know whether the new IBV isolates identified in this study were generated naturally through the recombination of GI-15, KM91-like, and QX-like field strains.

The S proteins of different genotypes of IBV have been identified as being associated with the emergence of novel variants with different tissue tropisms [5, 14, 33, 34] . Therefore, it is necessary to investigate potential differences in pathogenicity between recombinant IBV isolates. IBV isolates exhibit various tissue tropisms (e.g., respiratory, nephrotic, and gastrointestinal). In particular, the GI-19 strain shows stronger tropism and higher pathogenicity in the kidney than in the respiratory system. The GI-19 genotype also exhibits renal tropism, causing gross lesions that are pale, as well as swollen kidneys, with distention of the ureter and excess production of urates [25, 35] . However, none of the recombinant isolates in the present study caused severe clinical signs or pathologic lesions, especially nephritis, even though they harbored the partial S gene of GI-19 genotype strains and were detected in the trachea, kidney, and CT. Therefore, the results indicate that despite recombination with a GI-19 type IBV, the recombinant viruses are less likely to cause nephrotic syndrome in chickens.

The cilia in the trachea play an important role in innate immunity, and help to prevent infection by pathogenic microorganisms [36] . GI-19 and rGI-19s caused ciliostasis and lesions in the trachea at 7 dpi and 14 dpi. In particular, rGI-19-III, which has GI-15 as its major parent, generated more severe lesions than the other viruses. The combination of lesions and ciliostasis may decrease immunity and increase susceptibility to secondary infections. Thus, rGI-19s may be associated with a greater risk of secondary infection than GI-19.

Since the cross-protection provided by IB vaccines is limited, the failure of vaccineinduced immunity has been reported, as recombinants continue to emerge [37] . Therefore, it is crucial to gain a better understanding of the antigenicity and pathogenicity of recombinant GI-19 IBVs. Our data suggest that recombination between co-circulating nephropathogenic and respiratory IBVs is occurring in South Korea. Moreover, it is possible that these events might increase the genetic diversity of IBVs in the field, thereby preventing effective disease control. The efficacy of current vaccines against these isolates should be the subject of further study. Continuous testing of the pathogenicity and serotype of new isolates remains crucial to improving the epidemiological understanding and control of IB.

Isolation, propagation, identification and comparative pathogenicity of five Egyptian field strains of Eimeria tenella from broiler chickens in five different provinces in Egypt

Assessing the economic burden of avian infectious bronchitis on poultry farms in Brazil

Characterizatioin of three infectious bronchitis virus isolates from China associated with proventriculus in vaccinated chickens

Identification of a novel recombinant virulent avian infectious bronchitis virus

Recombinant Avian Infectious Bronchitis Virus Expressing a Heterologous Spike Gene Demonstrates that the Spike Protein Is a Determinant of Cell Tropism

Coronavirus IBV: Virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection

The pathogenesis of a new variant genotype and GI-19-like infectious bronchitis virus isolated from chickens in Thailand

Glycosylation of the viral attachment protein of avian coronavirus is essential for host cell and receptor binding

Mapping of the receptor-binding domain and amino acids critical for attachment in the spike protein of avian coronavirus infectious bronchitis virus

Effects of hypervariable regions in spike protein on pathogenicity, tropism, and serotypes of infectious bronchitis virus

Characterization and analysis of an infectious bronchitis virus strain isolated from southern China in 2013

Pathogenicity of a TW-like strain of infectious bronchitis virus and evaluation of the protection induced against it by a GI-19-Like strain

Molecular characteristic and pathogenicity analysis of a virulent recombinant avian infectious bronchitis virus isolated in China

Reviw of infectious bronchitis virus around the world

Genetic Diversity of Avian Infectious Bronchitis Virus Isolates in Korea Between

Pathogenicity and antigenicity of a new variant of Korean nephropathogenic infectious bronchitis virus

Characterization of a novel live attenuated infectious bronchitis virus vaccine candidate derived from a Korean nephropathogenic strain

An emerging recombinant cluster of nephropathogenic strains of avian infectious bronchitis virus in Korea

Multiple Genotypes of Avian Infectious Bronchitis Virus Circulating in Vietnam

BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT

Molecular evolutionary genetics analysis version 6.0

Full-Length Human Immunodeficiency Virus Type 1 Genomes from Subtype C-Infected Seroconverters in India, with Evidence of Intersubtype Recombination

New insights on infectious bronchitis virus pathogenesis: Characterization of Italy 02 serotype in chicks and adult hens

Development and evaluation of a real-time Taqman RT-PCR assay for the detection of infectious bronchitis virus from infected chickens

Phylogenetic analysis of infectious bronchitis coronaviruses newly isolated in China, and pathogenicity and evaluation of protection induced by GI-1achusetts serotype H120 vaccine against GI-19-like strains

Genetic Diversity of Spike, 3a, 3b and E Genes of Infectious Bronchitis Viruses and Emergence of New Recombinants in Korea

Molecular and epidemiological characteristics of infectious bronchitis virus isolated in Korea

Evolutionary implications of genetic variations in the S1 gene of infectious bronchitis virus

Identification of Taiwan and China-like recombinant avian infectioius bronchiis viruses in Taiwan

Evolution of infectious bronchitis virus in Taiwan: Characterization of RNA recombination in the nucleocapsid gene

Genetic Diversity of Avian Infectious Bronchitis Viruses in Japan Based on Analysis of S2 Glycoprotein Gene

Molecular epizootiology of infectious bronchitis virus in Sweden indicating the involvement of a vaccine strain

Retargeting of Coronavirus by Substitution of the Spike Glycoprotein Ectodomain: Crossing the Host Cell Species Barrier

Infectious bronchitis virus variants: A review of the history, current situation and control measures

Pathogenicity differences between GI-19-like and GI-1-type infectious bronchitis viruses

The role of respiratory epithelium in host defence against influenza virus infection

Infectious Bronchitis Virus Variants: Molecular Analysis and Pathogenicity Investigation